SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-125726
Filing Date
2023-12-13
Accepted
2023-12-13 16:36:00
Documents
6
Effectiveness Date
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2332599d1_s8.htm S-8 60560
2 EXHIBIT 5.1 tm2332599d1_ex5-1.htm EX-5.1 8984
3 EXHIBIT 23.1 tm2332599d1_ex23-1.htm EX-23.1 2166
4 EXHIBIT 23.2 tm2332599d1_ex23-2.htm EX-23.2 2215
5 EX-FILING FEES tm2332599d1_exfiling-fees.htm EX-FILING FEES 9591
6 GRAPHIC image_003.jpg GRAPHIC 2707
  Complete submission text file 0001104659-23-125726.txt   88679
Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276027 | Film No.: 231484461
SIC: 2834 Pharmaceutical Preparations